← Back to Search

Behavioral Intervention

El Faro Treatment for ADHD

N/A

Recruiting

Led By John Mitchell, PhD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 weeks

Awards & highlights

Study Summary

This trial will help Latinx families of children with ADHD understand & cope with the disorder. El Futuro & Duke will collaborate to pilot-test an adapted El Faro treatment.

Who is the study for?

This trial is for Latinx children aged 6-12 with ADHD, who are generally healthy and not on changing psychiatric meds. Their caregivers must be over 18. It's designed to help families cope with ADHD-related challenges.Check my eligibility

What is being tested?

The El Faro treatment intervention is being tested, which aims to support Latinx families in managing ADHD stress. The study will pilot-test this approach through a partnership between El Futuro and the Duke ADHD Program.See study design

What are the potential side effects?

Since El Faro is a psychosocial intervention rather than a medication, it may not have typical medical side effects but could include emotional discomfort or increased family tension during therapy sessions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of adapted El Faro Treatment as measured by caregiver perceptions

Acceptability of adapted El Faro Treatment as measured by how satisfactory participants felt that the treatment was overall

Feasibility of adapted El Faro Treatment as measured by homework compliance

+6 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Treatment ParticipantsExperimental Treatment1 Intervention

Active treatment group participants

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,364 Previous Clinical Trials

3,420,612 Total Patients Enrolled

3 Trials studying Mental Health

272 Patients Enrolled for Mental Health

John Mitchell, PhDPrincipal InvestigatorDuke University

1 Previous Clinical Trials

92 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scope of enrollment for this therapeutic trial?

"Affirmative. Clinicaltrials.gov corroborates that this investigation is currently seeking applicants; it was initially posted on October 10th 2023 and the latest update occurred November 6th 2023. A total of 30 participants are needed from a single medical facility."

Answered by AI

Are there still openings available for this experiment?

"Per the details hosted on clinicaltrials.gov, this research project is currently enlisting participants. The trial was first posted October 10th 2023 and most recently updated November 6th of that same year."

Answered by AI

Is there an age restriction to participate in this research endeavor?

"The parameters set for this trial indicate that only patients between 6 and 12 years of age are qualified to enroll."

Answered by AI

How can I join the cohort participating in this clinical trial?

"To qualify for this research protocol, enrollees must be between the ages of 6 and 12 years old with sound psychological health. Approximately 30 participants are needed to complete the study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

El Faro: Addressing Mental Health Inequities Among Latinx Children With ADHD in Durham

2023. "El Faro: Addressing Mental Health Inequities Among Latinx Children With ADHD in Durham". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05928182.

All > Adhd